Mannkind (MNKD) Depreciation & Amortization (CF) (2010 - 2026)
Mannkind (MNKD) reported Depreciation & Amortization (CF) of $6.4 million for Q1 2026, up 203.04% year-over-year from $2.1 million in Q1 2025, and up 5.84% on a QoQ basis from $6.0 million in Q4 2025.
Mannkind (MNKD) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $6.4 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 203.04% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.6 million (up 104.04% YoY) and the FY2025 annual result came in at $12.3 million, up 66.65% from the prior year.
- Depreciation & Amortization (CF) rose to $6.4 million in Q1 2026 per MNKD's latest filing, from $6.0 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $6.4 million in Q1 2026 and bottomed at $599000.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $1.4 million (2024), against an average of $2.0 million.
- The widest annual swing landed in 2022, when Depreciation & Amortization (CF) retreated 28.44%; it then jumped 203.04% in 2026.
- Tracing MNKD's Depreciation & Amortization (CF) over 5 years: stood at $1.0 million in 2022, then rose by 20.45% to $1.2 million in 2023, then jumped by 76.33% to $2.2 million in 2024, then jumped by 179.17% to $6.0 million in 2025, then rose by 5.84% to $6.4 million in 2026.
- Per Business Quant, the three latest MNKD Depreciation & Amortization (CF) figures stand at $6.4 million (Q1 2026), $6.0 million (Q4 2025), and $2.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.38 Mn |
| Mar 31, 2026 | 6.38 Mn |
| Dec 31, 2025 | 6.03 Mn |
| Dec 31, 2025 | 6.03 Mn |
| Sep 30, 2025 | 2.06 Mn |
| Sep 30, 2025 | 2.06 Mn |
| Jun 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 2.09 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.12 Mn |
| Sep 30, 2024 | 2.12 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.06 Mn |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 982,000.00 |
| Sep 30, 2022 | 982,000.00 |
| Jun 30, 2022 | 727,000.00 |
| Jun 30, 2022 | 727,000.00 |
| Mar 31, 2022 | 599,000.00 |
| Mar 31, 2022 | 599,000.00 |
| Dec 31, 2021 | -1.01 Mn |
| Dec 31, 2021 | -1.01 Mn |
| Sep 30, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.32 Mn |
| Jun 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 1.02 Mn |
| Mar 31, 2021 | 655,000.00 |
| Mar 31, 2021 | 655,000.00 |
| Dec 31, 2020 | 510,000.00 |
| Dec 31, 2020 | 510,000.00 |
| Sep 30, 2020 | 534,000.00 |
| Sep 30, 2020 | 534,000.00 |
| Jun 30, 2020 | 567,000.00 |
| Jun 30, 2020 | 567,000.00 |
| Mar 31, 2020 | 538,000.00 |
| Mar 31, 2020 | 538,000.00 |
| Dec 31, 2019 | 565,000.00 |
| Dec 31, 2019 | 565,000.00 |
| Sep 30, 2019 | -332,000.00 |
| Sep 30, 2019 | -332,000.00 |
| Jun 30, 2019 | 372,000.00 |
| Jun 30, 2019 | 372,000.00 |
| Mar 31, 2019 | 367,000.00 |
| Mar 31, 2019 | 367,000.00 |
| Dec 31, 2018 | 368,000.00 |
| Dec 31, 2018 | 368,000.00 |
| Sep 30, 2018 | 1.03 Mn |
| Sep 30, 2018 | 1.03 Mn |
| Jun 30, 2018 | 753,000.00 |
| Jun 30, 2018 | 753,000.00 |
| Mar 31, 2018 | 706,000.00 |
| Mar 31, 2018 | 706,000.00 |
| Dec 31, 2017 | 821,000.00 |
| Dec 31, 2017 | 821,000.00 |
| Sep 30, 2017 | 920,000.00 |
| Sep 30, 2017 | 920,000.00 |
| Jun 30, 2017 | 879,000.00 |
| Jun 30, 2017 | 879,000.00 |
| Mar 31, 2017 | 908,000.00 |
| Mar 31, 2017 | 908,000.00 |
| Dec 31, 2016 | 1.06 Mn |
| Dec 31, 2016 | 1.06 Mn |
| Sep 30, 2016 | 1.04 Mn |
| Sep 30, 2016 | 1.04 Mn |
| Jun 30, 2016 | 1.04 Mn |
| Jun 30, 2016 | 1.04 Mn |
| Mar 31, 2016 | 1.02 Mn |
| Mar 31, 2016 | 1.02 Mn |
| Dec 31, 2015 | 3.18 Mn |
| Dec 31, 2015 | 3.18 Mn |
| Sep 30, 2015 | 3.74 Mn |
| Sep 30, 2015 | 3.74 Mn |
| Jun 30, 2015 | 3.37 Mn |
| Jun 30, 2015 | 3.37 Mn |
| Mar 31, 2015 | 2.99 Mn |
| Mar 31, 2015 | 2.99 Mn |
| Dec 31, 2014 | 3.00 Mn |
| Dec 31, 2014 | 3.00 Mn |
| Sep 30, 2014 | 2.96 Mn |
| Sep 30, 2014 | 2.96 Mn |
| Jun 30, 2014 | 3.22 Mn |
| Jun 30, 2014 | 3.22 Mn |
| Mar 31, 2014 | 9.39 Mn |
| Mar 31, 2014 | 9.39 Mn |
| Dec 31, 2013 | 3.95 Mn |
| Dec 31, 2013 | 3.95 Mn |
| Sep 30, 2013 | 3.44 Mn |
| Sep 30, 2013 | 3.44 Mn |
| Jun 30, 2013 | 3.32 Mn |
| Jun 30, 2013 | 3.32 Mn |
| Mar 31, 2013 | 3.35 Mn |
| Mar 31, 2013 | 3.35 Mn |
| Dec 31, 2012 | 3.47 Mn |
| Dec 31, 2012 | 3.47 Mn |
| Sep 30, 2012 | 3.59 Mn |
| Sep 30, 2012 | 3.59 Mn |
| Jun 30, 2012 | 3.65 Mn |
| Jun 30, 2012 | 3.65 Mn |
| Mar 31, 2012 | 3.70 Mn |
| Mar 31, 2012 | 3.70 Mn |
| Dec 31, 2011 | 3.82 Mn |
| Dec 31, 2011 | 3.82 Mn |
| Sep 30, 2011 | 4.07 Mn |
| Sep 30, 2011 | 4.07 Mn |
| Jun 30, 2011 | 3.90 Mn |
| Jun 30, 2011 | 3.90 Mn |
| Mar 31, 2011 | 4.12 Mn |
| Mar 31, 2011 | 4.12 Mn |
| Dec 31, 2010 | 4.41 Mn |
| Dec 31, 2010 | 4.41 Mn |
| Sep 30, 2010 | 4.31 Mn |
| Sep 30, 2010 | 4.31 Mn |